In April 2009, this firm filed for chapter 7 banrupcty, clearing the way for their liquidation. Formerly known as Sonokinetics Inc until 1998, OmniSonics Medical Technologies, Inc. is an early stage medical device company dedicated to developing innovative medical devices based on proprietary technological platforms intended to improve patient outcomes and the standards and methodologies for the surgical ablation and removal of soft tissues. The company continues to develop proprietary products for a broad range of minimally invasive surgical procedures where rapid, precise soft tissue removal is required with minimal damage to surrounding tissues. FDA approval has been applied for to sell an acoustic device for unplugging blood vessels. In 2011 Cybersonics, Inc. purchased almost all of the assets of the former OmniSonics.